Multitarget anti-EBV therapy to prevent primary infection in kidney transplant recipients from deceased donor, at risk of post-transplantation lymphoproliferative disorder (EBV D+/R-).
Simon VilleJacques DantalPublished in: Transplant international : official journal of the European Society for Organ Transplantation (2020)